Health Condition 1: B465- Mucormycosis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Swati Datta
Dr Asim Kumar Kundu
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with RTPCR confirmed recent (with in last one & a half months) infection with SARS-COV-2 and current RTPCR negative status 2. Presence of more than 1 of following clinical features: i) Frontal headache ii) Blurring of vision iii) Numbness of chick iv) Facial swelling v) Features suggestive of cranial nerve involvement vi) Nasal or sinus congestion vii) Black lesion on nasal bridge or upper inside of mouth (palatal region) 3. Undergoing surgical resection of rhino-orbito-cerebral mucormycoses
Exclusion criteria
Exclusion criteria: 1. COVID-19 RTPCR positive mucormycosis 2. Patients with incomplete medical records 3. Post COVID mucormycosis patients who are critically ill, not undergoing surgical treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Sociodemographic profile of the post-COVID mucormycosis patients undergoing surgical intervention 2. Etiology of increased frequency of mucormycosis in the post-COVID period 3. Different anaesthetic challenges and ways to overcome them in post-COVID mucormycosis. 4. Association, if any, of zinc supplementation with post-COVID mucormycosisTimepoint: One and half months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Duration of hospital stay 2. Types of different surgeries performed 3. Duration of anaesthesia 4. Duration of mechanical ventilation in the post-operative period 5. Ocular morbidity of patients undergoing surgery for post-COVID mucormycosis 6. All cause mortalityTimepoint: one and half months | — |
Countries
India
Contacts
Public ContactDr Swati Datta
Medical College, Kolkata
Outcome results
None listed